Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 8/20 | 0.80 |
| ▸ | NADK | O95544 | 1/20 | 0.80 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.80 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.80 |
| ▸ | DPP4 | P27487 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.80 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.80 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.80 |
| ▸ | GAPDH | P04406 | 1/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.80 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.80 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.80 |
| ▸ | STAT6 | P42226 | 1/20 | 0.80 |
| ▸ | PI4KA | P42356 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.80 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.80 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6297859 | 1.00 | AHCY (0.80) | AHCYNADKADORA3DOT1LDPP4 | |
| SCHEMBL538531 | 1.00 | AHCY (0.80) | AHCYNADKADORA3DOT1LDPP4 | |
| SCHEMBL16057823 | 0.90 | ADORA1 (0.80) | AHCYNADKADORA3DOT1LDPP4 | |
| SCHEMBL784361 | 0.89 | AHCY (0.65) | AHCYNADKADORA3DOT1LDPP4 | |
| Adenosine SCHEMBL23420216 | 0.89 | ADORA3 (1.00) | AHCYNADKADORA3DOT1LDPP4 | |
| Adenosine SCHEMBL406207 | 0.89 | ADORA3 (1.00) | AHCYNADKADORA3DOT1LDPP4 | |
| Adenosine SCHEMBL23804425 | 0.89 | ADORA3 (1.00) | AHCYNADKADORA3DOT1LDPP4 | |
| Adenosine SCHEMBL2228590 | 0.89 | ADORA3 (1.00) | AHCYNADKADORA3DOT1LDPP4 | |
| Adenosine SCHEMBL1821276 | 0.89 | ADORA3 (1.00) | AHCYNADKADORA3DOT1LDPP4 | |
| SCHEMBL506314 | 0.89 | DOT1L (0.81) | AHCYNADKADORA3DOT1LDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160125-A1 | Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms | UNIVERSITY OF ROCHESTER (US) | 2006-07-20 | — | — | US | claimed |
| JP-2002515885-A | — | — | 2002-05-28 | — | — | JP | claimed |
| EP-0880353-A4 | COMPOSITIONS AND METHODS FOR MODULATING MELANIN PRODUCTION | THERASYS INC (US) | 2001-04-18 | — | — | EP | claimed |
| US-5998423-A | IN SKIN OR HAIR; ADMINISTERING ADENOSINE RECEPTOR ANTAGONIST | THERASYS, INC. (US) | 1999-12-07 | — | — | US | claimed |
| EP-0880353-A1 | COMPOSITIONS AND METHODS FOR MODULATING MELANIN PRODUCTION | Therasys, Inc. (US) | 1998-12-02 | — | — | EP | claimed |
| WO-1998015276-A1 | COMPOSITIONS AND METHODS FOR MODULATING MELANIN PRODUCTION | THERASYS, INC. (US) | 1998-04-16 | — | — | WO | claimed |
| CN-121678872-A | Method for detecting iodo-nucleoside in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2026-03-17 | — | — | CN | disclosed |
| US-20230017490-A1 | STING INHIBITORS AND THEIR THERAPEUTIC USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-01-19 | — | — | US | disclosed |
| EP-2677039-B1 | Detection of nucleic acid targets using chemically reactive oligonucleotide probes | DXTERITY DIAGNOSTICS (US) | 2022-08-17 | — | — | EP | disclosed |
| US-10829803-B2 | Detection of nucleic acid targets using chemically reactive oligonucleotide probes | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2020-11-10 | — | — | US | disclosed |
| US-20190106739-A1 | CHEMICAL LIGATION DEPENDENT PROBE AMPLIFICATION (CLPA) | DXTERITY DIAGNOSTICS INCORPORATED | 2019-04-11 | — | — | US | disclosed |
| US-10066257-B2 | Methods and compositions for detecting target nucleic acids | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2018-09-04 | — | — | US | disclosed |
| EP-1928475-B1 | ANTIVIRAL PHOSPHORAMIDATES OF 4'-C-AZIDO-SUBSTITUTED PRONUCLEOTIDES | RIBOSCIENCE LLC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| WO-1992020816-A1 | DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF | YALE UNIVERSITY (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0457326-A1 | Antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1991-11-21 | — | — | EP | disclosed |
| EP-0425680-A1 | NEW VITAMIN B 12? DERIVATIVE, PRODUCTION THEREOF, AND APPLICATION THEREOF | TEIJIN LIMITED (JP) | 1991-05-08 | — | — | EP | disclosed |
| EP-0126394-B1 | ENZYMATIC REMOVAL OF AROMATIC HYDROXY COMPOUNDS AND AROMATIC AMINES FROM WASTE WATERS | PHILLIPS PETROLEUM COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| EP-0126394-A1 | Enzymatic removal of aromatic hydroxy compounds and aromatic amines from waste waters | PHILLIPS PETROLEUM COMPANY (US) | 1984-11-28 | — | — | EP | disclosed |
| US-4485016-A | Enzymatic removal of aromatic hydroxy compounds and aromatic amines from waste waters | PHILLIPS PETROLEUM COMPANY (US) | 1984-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230017490-A1 | STING INHIBITORS AND THEIR THERAPEUTIC USES | STING1, CGAS, MAVS | AHCY 3830/4885NADK 1738/4885ADORA3 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.